Market Overview

2018 Pipeline Insights for Male Infertility; Featuring AlphaMab, Ferring International Center, Health Ever Bio-Tech, Navya Biologicals, PharmaEssentia, and TocopheRx - ResearchAndMarkets.com

Share:

The "Male
Infertility - Pipeline Insight, 2018"
drug pipelines has been
added to ResearchAndMarkets.com's offering.

This report offers a comprehensive insight of the pipeline (under
development) therapeutics scenario and growth prospects across Male
Infertility development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental
Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.

The report assesses the active Male Infertility pipeline products by
developmental stage, product type, molecule type, and administration
route.

Scope

  • The report provides a snapshot of the pipeline development for Male
    Infertility
  • The report covers pipeline activity across the complete product
    development cycle i.e. clinical, pre-clinical and discovery stages for
    Male Infertility
  • The report provides pipeline product profiles which includes product
    description, developmental activities, licensors & collaborators and
    chemical information
  • Provides pipeline assessment by monotherapy and combination therapy
    products, stage of development, route of administration, and molecule
    type for Male Infertility
  • The report also covers the dormant and discontinued pipeline projects
    related to Male Infertility

Companies Featured

  • AlphaMab Co Ltd
  • Ferring International Center SA
  • Health Ever Bio-Tech Co Ltd
  • Navya Biologicals Pvt Ltd
  • PharmaEssentia Corp
  • TocopheRx Inc

Key Topics Covered

1. Report Introduction

2. Male Infertility Overview

3. Pipeline Therapeutics

4. Comparative Analysis

5. Products in Clinical Stage

6. Products in Pre-Clinical and Discovery Stage

7. Therapeutic Assessment

8. Inactive Products

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/hd27qt/2018_pipeline?w=4

View Comments and Join the Discussion!